Showing results (1311-1320 of 1,341) with videos related to

Sort By:
Pageof 135
Eclinicalmedicine|October 20, 2020
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)Pablo Guisado-Vasco, Sofia Valderas-Ortega, Maria Maravillas Carralón-González, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2023
Climate determines transmission hotspots of Polycystic Echinococcosis, a life-threatening zoonotic disease, across Pan-AmazoniaAdrià San-José, Pedro Mayor, Bruno Carvalho, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5pMaider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
Clinical Genetics|July 11, 2024
The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variantsFrancesca Furia, Amanda M Levy, Miel Theunis, et al.
HGG Advances|June 26, 2026
Expanding the ABCA2-associated neurodevelopmental phenotypeKaisa T Oja, Karit Reinson, Mihkel Ilisson, et al.
Journal of Internal Medicine|October 6, 2021
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patientsMaría Martin-Vicente, Raquel Almansa, Isidoro Martínez, et al.
Vaccine|August 21, 2018
Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessmentDaniel Weibel, Miriam Sturkenboom, Steven Black, et al.
Lancet Regional Health. Americas|September 20, 2021
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trialArturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, et al.
European Journal of Human Genetics : EJHG|May 23, 2025
Biallelic loss-of-function variants in ZNF142 are associated with a robust DNA methylation signature affecting a limited number of genomic lociMathis Hildonen, Andrea Ciolfi, Marco Ferilli, et al.
Pageof 135